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Background: Serum amyloid A (SAA) is a kind of apolipoprotein. Several studies indicated that SAA genetic
polymorphism rs12218 was associated with carotid atherosclerosis, peripheral arterial disease, and serum uric acid
levels. However, the relation between rs12218 and lipid levels remains unclear. This study assessed the correlation
between SAA1 gene rs12218 polymorphism and lipid levels in a Chinese population.
Methods: A total of 823 participants were selected from the subjects for health check in Shanghai Huashan
hospital from Jan. 2013 to Mach. 2013. Correlations between rs12218 polymorphism and lipid levels were
investigated through the identification of rs12218 genotypes using the polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP).
Results: We found that the SNP rs12218 was associated with triglyceride (TG), total cholesterol (TC), and low-
density lipoprotein (LDL-C) levels by analyses of a dominant model (P<0.001, P=0.002, P=0.003, respectively), a
recessive model (P <0.001, P=0.001, P=0.005, respectively) and an additive model (P < 0.001, P=0.001, P=0.002,
respectively), and the difference remained significant after the adjustment of sex, age, alcohol intake, and smoking
(All P < 0.01).
Conclusion: Our results indicated that the rs12218 in the SAA1gene was associated with lipid levels in a Chinese
population.
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Serum amyloid A (SAA) is a kind of apolipoprotein and
is primarily synthesized in the liver by activated mono-
cytes and macrophages [1]. As an apolipoprotein, SAA is
associated with lipid level, such as high-density lipopro-
tein (HDL-C), and during inflammation can contribute
up to 80% of its apoprotein composition [2].
The human SAA gene cluster on the short arm of
chromosome 11, localized to band p15.1, contains four
related genes, SAA1-4, within a 150-kb region [3]. Only
the SAA1 and SAA2 genes encode acute-phase SAAs
(SAA1 and SAA2 proteins), so a lot of research focuses
on them. Recently, Carty et al. [4] reported an associ-
ation of SAA1 and SAA2 gene polymorphisms and ca-
rotid intima-media thickness (cIMT), HDL-C, and total
CVD. Many studies have demonstrated that rs12218 in* Correspondence: yiqingwang76@163.com
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reproduction in any medium, provided the orthe SAA1 gene was associated with carotid atheroscler-
osis [5] and peripheral arterial disease [6]. However, the
relationships between SAA gene polymorphism and
lipid level remain unclear.
In the present study, we aim to study the relationship
between SAA1 gene polymorphism (rs12218) and lipids
levels.Results and discussion
This study consists of 823 subjects. The clinical and
metabolic characteristics of the study population are
shown in Table 1.
The distribution of genotype was in Hardy-Weinberg
equilibrium (P>0.05, data not shown). Table 2 shows
detailed information for rs12218 as well as the allele
frequencies.
We found that the SNP rs12218 was associated with
triglyceride (TG), total cholesterol (TC), and low-density
lipoprotein (LDL-C) levels by analyses of a dominantThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of subjects
Risk factors No. (%) or Mean±SD
Male (n=654) Female (n=169)
Age (years) 53.2±11.8 54.1±10.7
Never drink (%) 421 (64.4) 118 (69.8)
Former drinker (%) 201(30.7) 32 (18.9)
Current drinker (%) 32 (4.9) 19 (11.2)
Never smoking (%) 452 (69.1) 131 (77.5)
Former smoking (%) 143 (21.9) 26 (15.4)
Current smoking (%) 59 (9.0) 12 (7.1)
BMI (Kg/m2) 24.4 ± 3.6 24.7 ± 3.9
SBP (mmHg) 124.4 ± 13.3 120.6 ± 10.1
DBP (mmHg) 78.7 ± 10.6 76.6 ± 7.4
GLU (mmol/L) 4.55 ± 0.81 4.43 ± 0.41
TG (mmol/L) 0.97 ± 0.37 0.99 ± 0.38
TC (mmol/L) 4.33 ± 0.91 4.18 ± 0.91
HDL (mmol/L) 1.03 ± 0.44 1.17 ±0.43
LDL-C (mmol/L) 2.68 ± 0.84 2.59±0.81
Table 2 Distribution of genotypes and alleles
Genotypes, n, % CC CT TT
129 (15.7) 332 (40.3) 362 (44.0)
Alleles, n, % C T
590 (35.8) 1056 (64.2)
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sive model (P <0.001, P=0.001, P=0.005, respectively)
and additive model (P < 0.001, P=0.001, P=0.002, re-
spectively), and the difference remained significant after
the adjustment of sex, age, alcohol intake, and smoking
(All P < 0.01) (Table 3).
In the present study, we found that variation in the
SAA1 gene is associated with TG, TC, and LDL-C levels
in Chinese population. In the early 1970s, SAA was
identified as the plasma protein responsible for forming
tissue deposits called “amyloid (AA-type)” seen in dis-
eases with underlying persistent acute inflammation
[7,8]. Soon after its discovery, SAA was shown to be anTable 3 Association of rs12218 with lipid levels
Rs12218
Lipid profile CC CT TT
R
TG (mmol/L) 0.72 ± 0.32 0.96±0.34 1.01 ±0.32 <0
TC (mmol/L) 3.94 ± 1.10 4.18 ± 0.94 4.32 ± 0.94 0
HDL-C (mmol/L) 1.26 ± 0.42 1.29 ± 0.45 1.31 ± 0.44 0
LDL-C (mmol/L) 2.43 ± 0.86 2.58± 0.79 2.70 ± 0.80 0
§analysis of covariance adjusted for sex, age, smoking, alcohol drinking, and GLU; ‡acute phase protein produced by the liver within hours of
tissue injury regardless of cause. Its plasma concentration
can increase a 1000-fold within 24 h [9,10]. In plasma,
SAA is associated with HDL-C [11,12] and, during severe
inflammation, can contribute 80% of its apo-protein com-
position [13]. The displaced apoA-I is rapidly cleared by
the liver and kidneys [14], together with a sharp decline in
apoA-I gene expression during inflammation [15]. A rela-
tionship between the SAA1 gene polymorphism and car-
diovascular diseases has been reported previously [1,2,4].
Previous studies have investigated the SAA1 rs12218 poly-
morphism in the Chinese population, but its relationship
with lipid level has not been thoroughly investigated. Xie
et al. [5] and Feng et al. [1] reported the relationship be-
tween rs12218 and lipid level, however, they did not reach
to the same conclusion. Feng et al. reported an association
between HDL-C concentration and rs12218, he found that
in the osteoporosis group the rs12218 was significantly
associated with plasma TC, HDL-C, and LDL-C levels
(P=0.021, P=0.009, and P=0.009, respectively). However,
this association was not found in the control group. And,
they did not find the TG level was significantly associated
with rs12218. Xie et al. also found rs12218 was signifi-
cantly associated with HDL-C concentration, but they did
not found the TG, LDL-C and TC was associated with
rs12218. In the present study, we found rs12218 associated
with TG, TC and LDL-C level both in the additive model,
but also in dominant model and recessive model. After ad-
justed for some confounders the difference remains sig-
nificant. This discrepancy may be result from the different
population selection. And the lager-sample study related
to this issue was expected.
Conclusions
In conclusion, the SAA1 gene polymorphism was asso-
ciated with lipid level in a Chinese population.
Subjects and methods
Subjects
This study was approved by the Ethics Committee of the
Shanghai Fudan University and was conducted according
to the standards of the Declaration of Helsinki. Written
informed consent was obtained from the participants. AModel 1‡ Model 2§
P P P P P P
ec* Dom† Add※ Rec* Dom† Add※
.001 <0.001 <0.001 <0.001 <0.001 <0.001
.003 0.002 0.001 0.001 0.002 0.001
.346 0.473 0.596 0.324 0.132 0.435
.005 0.003 0.002 0.012 <0.001 0.002
Unadjusted model; *recessive model; †dominant model; ※additive model.
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for health check in our hospital from Jan. 2013 to Mach.
2013 in Shanghai Huashan Hospital. These subjects were
free from diabetes, hypertension, or any history of coron-
ary artery disease (CAD). Height, body weight, and blood
pressure were measured as described previously [16,17].
Smoking and drinking status was self-reported by study
questionnaire as described previously [17]. We mea-
sured the fasting plasma concentration of total choles-
terol, triglyceride (TG), low-density lipoprotein (LDL),
high-density lipoprotein (HDL) and glucose using an
equipment for chemical analysis (Dimension AR/AVL
Clinical Chemistry System, Newark, NJ) employed by
the Clinical Laboratory Department of Shanghai Huashan
hospital.
Rs12218 genotyping
Genomic DNA was extracted from the peripheral blood
leukocytes using a DNA extraction Kit (Beijing Bioteke
Co. Ltd, China). We genotyped rs12218 according to the
protocol described previously [2]. To ensure the results
were verified, 10% of the genotyped samples were dupli-
cated, and at least one positive and one negative control
per 96-well DNA plate were used in our assays. The ac-
curacy of the genotyping was determined by assessing
the genotype concordance between duplicate samples.
We obtained a 100% concordance between the geno-
typed duplicate samples for the SNP. The genotyping
success rate was 100%.
Statistical analysis
All analyses were carried out using SPSS version 17.0
(SPSS Inc., Chicago, IL, USA). The Hardy-Weinberg
equilibrium was assessed using chi-square analysis. The
characteristics of the study population were expressed as
the mean ± standard deviation or as a ratio. Fasting tri-
glycerides were log-transformed using natural logarithms
for analysis. General linear model analysis was under-
taken to test for associations between SNP genotypes
and lipid levels after adjusting for confounding variables.
Single-SNP effects with continuous variables were ana-
lyzed using linear regression using three models. These
were the additive (common allele homozygotes coded as
1, heterozygotes as 2, and recessive allele homozygotes
as 3); dominant (common allele homozygotes coded as 1
and heterozygotes and recessive allele homozygotesas 2);
and recessive (common allele homozygotes and hetero-
zygotes coded as1 and recessive allele homozygotes as 2)
models as described previously [16]. Normality was
assessed by plotting the residuals.
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